Enzo Biochem, Inc.
ENZB · OTC
4/30/2025 | 1/31/2025 | 10/31/2024 | 7/31/2024 | |
|---|---|---|---|---|
| Market Cap | $25,153 | $31,687 | $60,081 | $59,558 |
| - Cash | $36,693 | $40,297 | $47,735 | $52,371 |
| + Debt | $3,003 | $3,138 | $3,036 | $3,509 |
| Enterprise Value | -$8,537 | -$5,472 | $15,382 | $10,696 |
| Revenue | $6,402 | $7,334 | $6,213 | $7,526 |
| % Growth | -12.7% | 18% | -17.4% | – |
| Gross Profit | $2,484 | $3,785 | $2,532 | $3,220 |
| % Margin | 38.8% | 51.6% | 40.8% | 42.8% |
| EBITDA | -$3,071 | -$1,284 | -$2,845 | $478 |
| % Margin | -48% | -17.5% | -45.8% | 6.4% |
| Net Income | -$2,790 | -$1,535 | -$3,376 | -$13,381 |
| % Margin | -43.6% | -20.9% | -54.3% | -177.8% |
| EPS Diluted | -0.05 | -0.029 | -0.065 | -0.26 |
| % Growth | -70.1% | 54.5% | 75.2% | – |
| Operating Cash Flow | -$3,220 | -$2,026 | -$8,990 | -$1,085 |
| Capital Expenditures | -$386 | -$70 | -$448 | -$123 |
| Free Cash Flow | -$3,606 | -$2,096 | -$9,438 | -$1,208 |